Modulation Of Prostate Cancer Genetic Risk By Ornega-3 And Ornega-6 Fatty Acids

Isabelle M. Berquin,Younong Min,Ruping Wu,Jiansheng Wu,Donna Perry,J. Mark Cline,Mike J. Thomas,Todd Thornburg,George Kulik,Adrienne Smith,Iris J. Edwards,Ralph D'Agostino,Hao Zhang,Hong Wu,Jing X. Kang,Yong Q. Chen
DOI: https://doi.org/10.1172/JCI31494
IF: 19.456
2007-01-01
Journal of Clinical Investigation
Abstract:Although a causal role of genetic alterations in human cancer is well established, it is still unclear whether dietary fat can modulate cancer risk in a predisposed population. Epidemiological studies suggest that diets rich in omega-3 polyunsaturated fatty acids reduce cancer incidence. To determine the influence of fatty acids on prostate cancer risk in animals with a defined genetic lesion, we used prostate-specific Pten-knockout mice, an immune-competent, orthotopic prostate cancer model, and diets with defined polyunsaturated fatty acid levels. We found that omega-3 fatty acids reduced prostate tumor growth, slowed histopathological progression, and increased survival, whereas omega-6 fatty acids had opposite effects. Introducing an omega-3 desaturase, which converts omega-6 to omega-3 fatty acids, into the Pten-knockout mice reduced tumor growth similarly to the omega-3 diet. Tumors from mice on the omega-3 diet had lower proportions of phosphorylated Bad and higher apoptotic indexes compared with those from mice on omega-6 diet. Knockdown of Bad eliminated omega-3-induced cell death, and introduction of exogenous Bad restored the sensitivity to omega-3 fatty acids. Our data suggest that modulation of prostate cancer development by polyunsaturated fatty acids is mediated in part through Bad-dependent apoptosis. This study highlights the importance of gene-diet interactions in prostate cancer.
What problem does this paper attempt to address?